Interact to see
Advertisement
Advertisement
CSSVX vs NRGSX
CSSVX vs NRGSX Comparison
Open Charts CSSVX vs NRGSX
Carillon Chartwell Small Cap R-6
Price$32.41
Change-$0.16 (-0.49%)
VolumeN/A
Net Assets230.53M
Neuberger Berman Genesis R6
Price$62.80
Change+$0.25 (+0.40%)
VolumeN/A
Net Assets8.71B
CSSVX vs NRGSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
CSSVX vs. NRGSX commentary
Oct 20, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSSVX is a Hold and NRGSX is a Hold.
FUNDAMENTALS
Fundamentals
NRGSX has more cash in the bank: 8.71B vs. CSSVX (231M). NRGSX pays higher dividends than CSSVX: NRGSX (0.06) vs CSSVX (0.00). CSSVX was incepted earlier than NRGSX: CSSVX (8 years) vs NRGSX (13 years). CSSVX (0.85) is less costly to investors than NRGSX (0.74). CSSVX is a more actively managed with annual turnover of: 27.00 vs. NRGSX (13.00). CSSVX (0) and NRGSX (0) have matching initial minimum investment requirements. CSSVX annual gain was more profitable for investors over the last year : -1.70 vs. NRGSX (-10.12). CSSVX return over 5 years is better than : 2.59 vs. NRGSX (-2.32).
| CSSVX | NRGSX | CSSVX / NRGSX | |
| Total Expense Ratio | 0.85 | 0.74 | 115% |
| Annual Report Gross Expense Ratio | 0.85 | 0.74 | 115% |
| Fund Existence | 8 years | 13 years | - |
| Gain YTD | 9.604 | -3.902 | -246% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 231M | 8.71B | 3% |
| Annual Yield % from dividends | 0.00 | 0.06 | - |
| Returns for 1 year | -1.70 | -10.12 | 17% |
| Returns for 3 years | 32.18 | 5.90 | 545% |
| Returns for 5 years | 2.59 | -2.32 | -112% |
| Returns for 10 years | N/A | 10.24 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JFNAX | 73.75 | 0.46 | +0.63% |
| Janus Henderson Global Life Sciences A | |||
| GGCCX | 102.84 | 0.38 | +0.37% |
| Gabelli Growth C | |||
| GMCUX | 16.77 | 0.04 | +0.24% |
| Goldman Sachs Small/Mid Cap Equity R6 | |||
| RLEFX | 38.98 | 0.04 | +0.10% |
| American Funds American Balanced R5E | |||
| MSECX | 11.32 | 0.01 | +0.09% |
| Morgan Stanley Inst International Eq C | |||